Plasma cytokines and future risk of Non-Hodgkin Lymphoma (NHL): A case-control study nested in the Italian European prospective investigation into cancer and nutrition

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 6, 2010, Pages 1577-1584

  Hosnijeh, Fatemeh Saberi ^a,c   Krop, Esmeralda J M ^a   Scoccianti, Chiara ^d,j   Krogh, Vittorio ^e   Palli, Domenico ^f   Panico, Salvatore ^g   Tumino, Rosario ^h   Sacredote, Carlotta ⁱ   Nawroly, Niga ^j   Portengen, Lützen ^a   Linseisen, Jakob ^k   Vineis, Paolo ^j   Vermeulen, Roel ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF ZANJAN   (Iran)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f Scientific Institute of Tuscany   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h Ragusa Cancer Registry   (Italy)

ⁱ ISI FOUNDATION   (Italy)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NUTRITIONAL HEALTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; IMMUNOLOGY; ITALY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; ITALY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953311151     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1237     Document Type: Article

References (26)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification - from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol 2000;11:3-10.
2. Skibola CF. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:392-5.
3. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:405-8.
4. Engels EA, Cerhan JR, Linet MS, et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005;162:1153-61.
5. Engels E. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:401-4.
6. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1-12. (Pubitemid 39625035)
7. Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer 1999;35:627-33.
8. Morgen G, Vornanen M, Puitinen J, Naukkarinen A, Brincker H, Oslen J. Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Ann Oncol 1997;8:S49-54.
9. Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin lymphoma. Clin Lymphoma 2003;4:161-8.
10. Vineis P, D'Amore F, Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy. The role of occupational exposure and immunodeficiency in B-cell malignancies. Epidemiology 1992;3:266-70.
11. Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphomas: a report from InterLymph Consortium. Lancet Oncol 2006;7:27-38.
12. Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006;107:4101-8.
13. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007;67:5042-54.
14. Bel Hadj Jrad B, Chatti A, Laatiri A, et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur J Haematol 2006;78:117-22.
15. Purdue MP, Lan Q, Kricker A, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: finding from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2007;28:704-12.
16. Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007;110:4455-63.
17. Breen EC, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Martinez-Maza O. The development of AIDS-associated Burkitt's/small non-cleaved lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol 1999;92:293-8.
18. Breen EC, Boscardin WJ, Detels R, et al. Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter-592 C/C genotype. Clin Immunol 2003;109:119-29.
19. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
20. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003;10:133-9.
21. Saberi Hosnijeh F, Krop EJM, Portengen L, et al. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic persons. Biomarkers 2010;15:140-8.
22. Lubin JH, Colt JS, Camann D, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Prospect 2004;112:1691-6.
23. Rothlein R, Cajkowski M, O'neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol 1988;141:1665-9.
24. Roos E. Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev 1991;10:33-48.
25. Mori T, Takada R, Watanabe R, Okamoto S, Ikeda Y. T-helper (Th) 1/(Th)2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma. Cancer Immunol Immunother 2001;50:566-8.
26. Jason J, Archibald LK, Nwanyanwu OC, et al. Comparison of serum and cell-specific cytokines in humans. Clin Diagn Lab Immunol 2001;8:1097-103.